SC
NVO

Sapient Capital’s Novo Nordisk NVO Stock Holding History

Sapient Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$480K Hold
12,651
– – 0.01% 263
2026
Q2 		$606K Hold
12,651
– – 0.01% 247
2026
Q1 		$481K Sell
12,651
-6,535
-34% -$310K 0.01% 277
2025
Q4 		$983K Buy
19,186
+810
+4% +$41.4K 0.01% 202
2025
Q3 		$1.02M Buy
18,376
+262
+1% +$15.3K 0.02% 191
2025
Q2 		$1.25M Sell
18,114
-36,184
-67% -$2.46M 0.02% 165
2025
Q1 		$3.83M Sell
54,298
-597,557
-92% -$49.4M 0.08% 109
2024
Q4 		$56.1M Buy
651,855
+11,576
+2% +$1.25M 1.07% 17
2024
Q3 		$76.2M Buy
640,279
+4,429
+0.7% +$591K 1.53% 14
2024
Q2 		$90.8M Buy
635,850
+5,622
+0.9% +$745K 1.89% 12
2024
Q1 		$81.5M Sell
630,228
-1,381
-0.2% -$164K 1.81% 11
2023
Q4 		$65.3M Buy
+631,609
New +$62.5M 1.69% 10

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Sapient Capital's NVO Position: Q3 2026 in Review

Sapient Capital held its Novo Nordisk (NVO) position steady in Q3 2026 at 12,651 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #263.

Sapient Capital first reported a position in NVO in Q4 2023 and has held it in 12 quarters since. The position peaked at $90.8M in Q2 2024. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Sapient Capital held 12,651 shares of Novo Nordisk worth $480K as of Q3 2026.
  • Sapient Capital left its Novo Nordisk share count unchanged in Q3 2026.
  • Novo Nordisk made up 0.01% of Sapient Capital's portfolio in Q3 2026, its #263 holding.
  • Sapient Capital first reported a position in Novo Nordisk in Q4 2023 and has held it in 12 quarters since.
  • Sapient Capital's Novo Nordisk position peaked at $90.8M in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.